Shares of Faron Pharmaceuticals Oy (LON:FARN – Get Free Report) crossed below its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of GBX 42.87 and traded as low as GBX 40. Faron Pharmaceuticals Oy shares last traded at GBX 40.08, with a volume of 45,991 shares.
Faron Pharmaceuticals Oy Price Performance
The stock has a market cap of £81.31 million, a price-to-earnings ratio of -1.82 and a beta of 1.12. The company has a debt-to-equity ratio of -133.35, a current ratio of 0.84 and a quick ratio of 1.09. The stock’s 50 day simple moving average is GBX 42.87 and its two-hundred day simple moving average is GBX 76.03.
About Faron Pharmaceuticals Oy
Faron (AIM: FARN, First North: FARON) is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with significant unmet needs. The Company currently has a pipeline based on the receptors involved in regulation of immune response in oncology and organ damage. Clevegen (bexmarilimab), its investigative precision immunotherapy, is a novel anti-Clever-1 antibody with the ability to switch immune suppression to immune activation in various conditions, with potential across oncology, infectious disease and vaccine development.
Further Reading
- Five stocks we like better than Faron Pharmaceuticals Oy
- Why Fastenal’s Latest Drop Could Be Its Biggest Opportunity Yet
- 3 Overlooked Energy ETFs Delivering Strong Returns and Income
- 3 Space Stocks That Could Outshine SpaceX After Its IPO
- JPMorgan’s Q2 Strength Gives the Stock Rally New Support
Receive News & Ratings for Faron Pharmaceuticals Oy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Faron Pharmaceuticals Oy and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.png){kind=logo}
-logo-1200x675.png){kind=logo}